{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:39Z","timestamp":1792096359075,"version":"4.4.0"},"reference-count":53,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2017,7,24]]},"DOI":"10.1080\/14656566.2017.1346085","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T07:22:10Z","timestamp":1498634530000},"page":"1137-1143","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis"],"prefix":"10.1080","volume":"18","author":[{"given":"Alexei","family":"Gonzalez-Estrada","sequence":"first","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthi","family":"Reddy","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ves","family":"Dimov","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Eidelman","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,7,9]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.06.003"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.1_suppl.21S"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.10.014"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X112552"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.485609"},{"key":"e_1_3_2_8_1","unstructured":"Patanase nasal spray prescribing information. Alcon 2017 [cited 2017 Mar 14]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021861s009lbl.pdf"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1996.12.389"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61025-3"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61174-X"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S83263"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000562"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200929070-00003"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.88.379"},{"key":"e_1_3_2_16_1","unstructured":"Patanol prescribing information: 2017. [cited 2017 Mar 14]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2003\/20688slr016_patanol_lbl.pdf"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2010.31.3317"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2010.31.3355"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.485413"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2007.28.3062"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2009.30.3298"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070030090035"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00044-0"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S3294"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80106-5"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0156-2"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125004330"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X5724"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80007-8"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83044-1"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80055-7"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.09.013"},{"key":"e_1_3_2_33_1","first-page":"399","article-title":"Comparison of olopatadine and ketotifen in the treatment of allergic conjunctivitis","volume":"47","author":"Varguez-Rodriguez ME","year":"2009","unstructured":"Varguez-Rodriguez ME, Hernandez-Lopez A, Gomez-Davila Rde L. Comparison of olopatadine and ketotifen in the treatment of allergic conjunctivitis. Rev Med Inst Mex Seguro Soc. 2009;47:399\u2013404.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"e_1_3_2_34_1","first-page":"6","article-title":"Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis","volume":"1","author":"Castillo M","year":"2015","unstructured":"Castillo M, Scott NW, Mustafa MZ, et al. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev. 2015;1:6.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80060-1"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S15788"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S15379"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)80065-1"},{"key":"e_1_3_2_39_1","first-page":"69","article-title":"Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration","volume":"25","author":"Vogelson CT","year":"2004","unstructured":"Vogelson CT, Abelson MB, Pasquine T, et al. Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration. Allergy Asthma Proc. 2004;25:69\u201375.","journal-title":"Allergy Asthma Proc"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02877768"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701736558"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X188206"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S38671"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0155-3"},{"key":"e_1_3_2_45_1","unstructured":"Pazeo prescribing information: 2017. [cited 2017 Mar 14]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/206276s000lbl.pdf"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X43622"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01952.x"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2008.29.3176"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2008.29.3181"},{"key":"e_1_3_2_50_1","unstructured":"Pataday prescribing information: 2017. [cited 2017 Mar 14]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/021545s000_PRNTLBL.pdf"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2000.078s230016.x"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ICL.0000063576.32087.F7"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60408-5"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2012.33.3565"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.06.008"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2017.1346085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:07:36Z","timestamp":1770916056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2017.1346085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,9]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,7,24]]}},"alternative-id":["10.1080\/14656566.2017.1346085"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2017.1346085","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-04-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}